Cell and Gene Therapy Market Key Drivers, On-going Trends and Future Forecast During 2018-2026 Appraised By Global Players Amgen, Biogen, Bristol-Myers Squibb Company, GlaxoSmithKline
Gene therapy aims at influencing the course of various genetic and acquired disorders at the genetic level whereas cell therapy targets various diseases at the cellular level i.e. by restoration of a certain cell population or using cells as carriers of therapeutic carrier. High prevalence of cardiovascular disease is expected to propel demand for cell and gene therapy, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), May 2017, around 17.9 million people died due to cardiovascular disease in 2016 globally, which accounts for 31% of all worldwide deaths. According to WHO, in 2012, cancer was the second leading cause of morbidity and mortality globally, with around 14 million new cases registered in 2012 and in 2015, cancer was responsible for 8.8 million deaths, worldwide. Moreover, WHO stated that the number of new cases is expected to rise by around 70% by 2030.
Furthermore, introduction of effective guidelines is expected to propel growth of the global cell and gene therapy market over the forecast period. For instance, the U.S. Food and Drug Administration (FDA) included around 28 guidelines documents from 1998 to 2018 regarding various cell and gene therapies.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2475
Cell therapy is the administration of living cells in patients for the treatment of a disease. The source of cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the patient's genetic code for treatment of a disease. Moreover, it modifies the expression of an individual’s genes or repair abnormal genes. The therapy involves administration of nucleic acid (DNA/RNA) with carriers called as vectors.
Increasing prevalence of cancer diseases is a major factor driving the cell and gene therapy market growth. According to the World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, introduction of innovative products and rich pipeline of cell and gene therapy is expected to boost the market growth. For instance, around 150 gene therapies are currently in the development stage. Gene replacement accounts for around two third of gene therapy pipeline. However, around 49% of gene therapies are under preclinical and discovery stages. During 2012-18, around 351 gene therapy deals were signed. For instance Gilead’s Kite Pharma received exclusive rights to Sangamo Therapeutics’ zinc finger nuclease gene editing technology, for $3.2bn.
Increasing Prevalence Of Neurological Disorders In North America Is Expected To Bolster The Market Growth
North America holds dominant position in the global cell and gene therapy market, owing to high prevalence of genetic disorders. According to the U.S. Pharmacist Journal, January 2018, annually, around 1.2 million adults are diagnosed with early symptoms of brain disorders, of which 21% are due to Alzheimer’s disease, and the total number of new cases of Parkinson’s disease and traumatic brain injuries is around 135 million in U.S.
Moreover, increasing research and development activities is expected to increase demand for cell and gene therapy. According to the Catalyst report, in December 2018, around 289 novel cell and gene therapies were in development for a variety of diseases, of which around 111 medicines were for cancer and around 28 medicines were for cardiovascular disease. These medicines in development are either in clinical trials or awaiting for approval from the U.S. Food and Drug Administration (FDA).
Major players operating in the global cell and gene therapy market include Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi, Spark Therapeutics, Agilis Biotherapeutics, Angionetics AVROBIO, Freeline Therapeutics, Horama, MeiraGTx, Myonexus Therapeutics, Nightstar Therapeutics, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., and MEDIPOST.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2475
• Global Cell and Gene Therapy Market, By Therapy Type:
◦ Cell Therapy
▪ Stem Cells
▪ T Cells
▪ Dendritic Cells
▪ NK Cells
▪ Tumor Cells
◦ Gene Therapy
• Global Cell and Gene Therapy Market, By Indication:
◦ Cardiovascular Disease
◦ Genetic Disorder
◦ Infectious Disease
◦ Neurological Disorders
• Global Cell and Gene Therapy Market, By Scale of Operation:
◦ In House
• Global Cell and Gene Therapy Market, By Geography:
◦ North America
◦ Asia Pacific
◦ Latin America
◦ Middle East
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Market Key Drivers, On-going Trends and Future Forecast During 2018-2026 Appraised By Global Players Amgen, Biogen, Bristol-Myers Squibb Company, GlaxoSmithKline here
News-ID: 1796420 • Views: 630
More Releases from Coherent Market Insights
Bispecific Antibodies Market 2020-2026 Status, Size By Players, Regions, Type, A …
Bispecific Antibodies Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Bispecific Antibodies industry overview and then goes into each and every detail. Bispecific Antibodies Market Report contains in-depth information on major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Bispecific Antibodies also provides data about the company and its operations. This report also provides information on the
n-hexane market to Register Substantial Expansion by 2027 With Top Players Exxon …
n-Hexane Market: In-Depth Research On Market Dynamics, Emerging Growth Factors And Forecasts To 2019 - 2027. The report serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts. The report aims to provide an overview of global n-Hexane market with detailed market segmentation by product/application and geography. This market is expected to witness high growth during the forecast period. The report also focuses on
Lithium Carbonate Market Key Trends In Terms Of Volume And Value 2020-2027 | SQM …
Lithium Carbonate Market: In-Depth Research On Market Dynamics, Emerging Growth Factors And Forecasts To 2019 - 2027. The report serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts. The report aims to provide an overview of global Lithium Carbonate market with detailed market segmentation by product/application and geography. This market is expected to witness high growth during the forecast period. The report also
Temperature Controlled Packaging Market to Witness Rapid Increase in Consumption …
The global Temperature Controlled Packaging Market report serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts, about the Kewyord Market. The global Temperature Controlled Packaging Market research report thoroughly explains each and every aspect related to the Temperature Controlled Packaging Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. Key
More Releases for Cell
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Global Cell Therapy Market & Cell Therapy Clinical Pipeline Outlook 2022
The cell therapy industry is rapidly growing industry with the several new products that having been accepted for clinical use over the past few years. There are many challenges that need to be resolved wisely before the cell therapies are widely accepted, including the optimization of their manufacture. There is much to be explored about the specific features of the stem cells and about the efficacy and safety of the
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of